Drug Type Interleukins |
Synonyms 辛洛尔 |
Target |
Action agonists, stimulants |
Mechanism IL-2R agonists(Interleukin-2 receptor agonists), Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 1997), |
Regulation- |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Kidney Neoplasms | China | 01 Sep 2008 | |
| Malignant ascites | China | 01 Sep 2008 | |
| Malignant Pleural Effusion | China | 01 Sep 2008 | |
| Melanoma | China | 01 Sep 2008 | |
| Thrombocytopenia | China | 01 Jan 1997 |






